Matches in Wikidata for { <http://www.wikidata.org/entity/Q44355349> ?p ?o ?g. }
- Q44355349 description "2015 nî lūn-bûn" @default.
- Q44355349 description "2015 թվականի ապրիլի 7-ին հրատարակված գիտական հոդված" @default.
- Q44355349 description "2015年の論文" @default.
- Q44355349 description "2015年学术文章" @default.
- Q44355349 description "2015年学术文章" @default.
- Q44355349 description "2015年学术文章" @default.
- Q44355349 description "2015年学术文章" @default.
- Q44355349 description "2015年学术文章" @default.
- Q44355349 description "2015年学术文章" @default.
- Q44355349 description "2015年學術文章" @default.
- Q44355349 description "2015年學術文章" @default.
- Q44355349 description "2015年學術文章" @default.
- Q44355349 description "2015年學術文章" @default.
- Q44355349 description "2015年學術文章" @default.
- Q44355349 description "2015년 논문" @default.
- Q44355349 description "article científic" @default.
- Q44355349 description "article scientific" @default.
- Q44355349 description "article scientifique" @default.
- Q44355349 description "articol științific" @default.
- Q44355349 description "articolo scientifico" @default.
- Q44355349 description "artigo científico" @default.
- Q44355349 description "artigo científico" @default.
- Q44355349 description "artigo científico" @default.
- Q44355349 description "artikel ilmiah" @default.
- Q44355349 description "artikull shkencor" @default.
- Q44355349 description "artikulong pang-agham" @default.
- Q44355349 description "artykuł naukowy" @default.
- Q44355349 description "artículo científico publicado en 2015" @default.
- Q44355349 description "artículu científicu" @default.
- Q44355349 description "bilimsel makale" @default.
- Q44355349 description "bài báo khoa học" @default.
- Q44355349 description "naučni članak" @default.
- Q44355349 description "scienca artikolo" @default.
- Q44355349 description "scientific article published on 7 April 2015" @default.
- Q44355349 description "scientific article published on 7 April 2015" @default.
- Q44355349 description "scientific article published on 7 April 2015" @default.
- Q44355349 description "teaduslik artikkel" @default.
- Q44355349 description "tieteellinen artikkeli" @default.
- Q44355349 description "tudományos cikk" @default.
- Q44355349 description "vedecký článok" @default.
- Q44355349 description "vetenskaplig artikel" @default.
- Q44355349 description "videnskabelig artikel" @default.
- Q44355349 description "vitenskapelig artikkel" @default.
- Q44355349 description "vitskapeleg artikkel" @default.
- Q44355349 description "vědecký článek" @default.
- Q44355349 description "wetenschappelijk artikel" @default.
- Q44355349 description "wissenschaftlicher Artikel" @default.
- Q44355349 description "επιστημονικό άρθρο" @default.
- Q44355349 description "мақолаи илмӣ" @default.
- Q44355349 description "наукова стаття, опублікована у квітні 2015" @default.
- Q44355349 description "научна статия" @default.
- Q44355349 description "научная статья" @default.
- Q44355349 description "научни чланак" @default.
- Q44355349 description "научни чланак" @default.
- Q44355349 description "מאמר מדעי" @default.
- Q44355349 description "مقالة علمية نشرت في 7 أبريل 2015" @default.
- Q44355349 description "৭ এপ্রিল ২০১৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q44355349 description "บทความทางวิทยาศาสตร์" @default.
- Q44355349 description "სამეცნიერო სტატია" @default.
- Q44355349 name "RECORD-2: phase II randomized study of everolimus and bevacizumab versus interferon α-2a and bevacizumab as first-line therapy in patients with metastatic renal cell carcinoma" @default.
- Q44355349 name "RECORD-2: phase II randomized study of everolimus and bevacizumab versus interferon α-2a and bevacizumab as first-line therapy in patients with metastatic renal cell carcinoma" @default.
- Q44355349 type Item @default.
- Q44355349 label "RECORD-2: phase II randomized study of everolimus and bevacizumab versus interferon α-2a and bevacizumab as first-line therapy in patients with metastatic renal cell carcinoma" @default.
- Q44355349 label "RECORD-2: phase II randomized study of everolimus and bevacizumab versus interferon α-2a and bevacizumab as first-line therapy in patients with metastatic renal cell carcinoma" @default.
- Q44355349 prefLabel "RECORD-2: phase II randomized study of everolimus and bevacizumab versus interferon α-2a and bevacizumab as first-line therapy in patients with metastatic renal cell carcinoma" @default.
- Q44355349 prefLabel "RECORD-2: phase II randomized study of everolimus and bevacizumab versus interferon α-2a and bevacizumab as first-line therapy in patients with metastatic renal cell carcinoma" @default.
- Q44355349 P1433 Q44355349-F137591E-67A1-410D-A5F8-FC5692728D3C @default.
- Q44355349 P1476 Q44355349-E9F9A954-BC9D-4B11-8AB6-8B156B7462BA @default.
- Q44355349 P2093 Q44355349-199ACA19-5E49-4847-8951-779C97E5AFD0 @default.
- Q44355349 P2093 Q44355349-2184D4D9-082F-4DF8-96E5-0DFC1AE4FFCB @default.
- Q44355349 P2093 Q44355349-29F68F5A-04F4-43FA-9F91-130B7034C872 @default.
- Q44355349 P2093 Q44355349-433107F7-3CD2-4E13-903F-D92BE6D8CBCB @default.
- Q44355349 P2093 Q44355349-5B5ADFE9-266B-4052-AD9B-AA5917C71019 @default.
- Q44355349 P2093 Q44355349-5C956852-5C05-4C1C-B5EE-3850C6FD1FC5 @default.
- Q44355349 P2093 Q44355349-632E12D7-32CB-4A1C-BEFF-11DBA6CD1469 @default.
- Q44355349 P2093 Q44355349-6F8B683A-82B7-49A0-B6F3-3D2AA73BDFDD @default.
- Q44355349 P2093 Q44355349-73B44446-2B41-4363-9FA3-F6DF81560646 @default.
- Q44355349 P2093 Q44355349-98AD79D3-AF28-4920-9640-8E6A40DFA130 @default.
- Q44355349 P2093 Q44355349-AA662576-B731-4B57-BC78-A971A0371717 @default.
- Q44355349 P2093 Q44355349-C767AC96-7CC9-4FFC-98BD-D8ACB253920A @default.
- Q44355349 P2093 Q44355349-CC15EC55-F0EE-41DF-ABF9-FD26F846EA85 @default.
- Q44355349 P2860 Q44355349-03BCEBBB-44B5-47CE-97D0-D9A58E074B3C @default.
- Q44355349 P2860 Q44355349-052E50D0-3BC6-4084-A9E2-E3B363AD5A22 @default.
- Q44355349 P2860 Q44355349-1D48B8FE-2E9B-4BBB-A075-3FCB97FAC60C @default.
- Q44355349 P2860 Q44355349-4C6B41BF-FFD4-4B1F-A762-4BE3AD8F0335 @default.
- Q44355349 P2860 Q44355349-5AAE1F9F-FA85-4D3D-8049-26FEDBBFACC8 @default.
- Q44355349 P2860 Q44355349-5F507B5E-4591-43C0-B1C8-FD88FBEC3D66 @default.
- Q44355349 P2860 Q44355349-61A4057F-247D-46D0-8044-448BA69F3C29 @default.
- Q44355349 P2860 Q44355349-6CDA447E-FC40-4C9B-80E5-B20F00B8FF5C @default.
- Q44355349 P2860 Q44355349-6D97FE23-1549-4E82-B8D9-D553B1995160 @default.
- Q44355349 P2860 Q44355349-72CDEF28-072B-4F26-A72D-B7C47F1CDF65 @default.
- Q44355349 P2860 Q44355349-C8282073-A0A3-48E8-8469-8D7DE8145C46 @default.
- Q44355349 P2860 Q44355349-D6AD84EF-4F85-49DE-80B2-E6D87F9BDDF8 @default.
- Q44355349 P2860 Q44355349-E7313B57-828C-4C5A-B57C-ED7A6124BE6A @default.
- Q44355349 P2860 Q44355349-EB54F234-0EB0-4C29-9150-A9BA9CF8911D @default.
- Q44355349 P2860 Q44355349-EE183653-65B9-4244-8A49-1B8279043B94 @default.
- Q44355349 P304 Q44355349-EBA3EB2C-D217-4038-B3AF-562F8375CA42 @default.
- Q44355349 P31 Q44355349-A4BB2F1C-F051-46F6-8D68-624E6A9DEBBA @default.
- Q44355349 P356 Q44355349-58618BC5-0D6E-4CC8-83B2-39C6EE613610 @default.
- Q44355349 P407 Q44355349-EB46A0E9-DB14-4B58-AAED-19311FBDAB4E @default.